Medicinal nutrition is developed to maintain the health of individuals. Orthomolecular medicine is an important part of the treatment protocol to help improve the quality of patient’s life.
The major focus of orthomolecular medicine is optimizing the biological functioning in our bodies’ core biochemical/physiological systems. Orthomolecular medicine utilizes nourishment and supplementation as vital remedial metabolic tools that are effective and modest.
Prescription has neglected to perceive that supplements are multifunctional metabolic substances with numerous biochemical/physiological parts. Nutritional and dietary supplementation, in light of learning of healthful prerequisites, nourishing status and specific genotype (i.e., individualized orthomolecular medicine), can be utilized to prevent or cure interminable illness.
Orthomolecular medicines can likewise compensate for supplement lacks or deficiencies that, if uncorrected, may lead to interminable or chronic illnesses.
Another logical method of reasoning for orthomolecular medicine stems, to a limited extent, from the acknowledgment that modified enzymatic functionality because of twisted chemical structures can be metabolically revised by the organization of supraphysiologic measurements of supplements.
Managing nutrition and health is becoming a major concern across many regions. In order to maintain nutrition and health, orthomolecular medicine is increasingly emerging as an essential component in providing an appropriate medical diet.
Orthomolecular medicine is widely used by doctors and experts to provide the right diet to patients and support the right nutrition for patients, babies and mothers.
Orthomolecular medicines are designed for the sick, elderly, children and patients suffering from metabolic disorders. It helps them fulfil their nutrition status and boosts their immune system to support their medical conditions.
The orthomolecular medicine is segmented on the basis of products such as infant nutrition, parenteral nutrition and enteral nutrition. One of the key insights of modern nutritional science is that health in early stages of life has a huge impact on our life. Infant nutrition helps the child maintain its nutritional needs for proper growth and development.
Parenteral nutrition involves feeding the person intravenously bypassing the usual activity of eating and digestion. Parenteral nutrition usually contains nutritional formulas such as amino acids-based, glucose-based, dextrose-based, lipid-based and vitamins-based. Enteral nutrition refers to any method of feeding nutrition that requires the involvement of gastrointestinal (GI) tract.
Enteral nutrition involves standardized slow feeding, elemental and semi-elemental and specialized enteral nutrition.
The global market for orthomolecular medicine is expected to be driven by the increasing aging population, increasing prevalence of chronic diseases associated with metabolic diseases, fragility, Alzheimer’s disease, etc. The key drivers of the market include the increasing prevalence of cancer and the under-nutrition cases associated with it.
Increasing concerns regarding aging health problems are expected to drive the market throughout the forecast period. However, cost and critical reimbursement scenarios are expected to act as hurdles for the growth of this market.
Increasing investments by governments and public organizations aimed at ensuring adequate nutritional quantity are expected to drive the market. Companies are focused on introducing products with innovative formulas.
Based on the product type, orthomolecular medicines are divided into infant nutrition, parenteral nutrition, which can be further segmented into amino acids-based, glucose-based, dextrose-based, lipid-based, vitamins-based, and enteral nutrition, which can be further segmented into standardized, elemental/ semi-elemental and specialized enteral nutrition.
By distribution channel, the global orthomolecular medicine market can be segmented into hospitals, pharmacies, private clinics, drug stores, retail pharmacies and E-commerce.
By regional presence, the orthomolecular medicine market can be segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and the Middle East & Africa. North America will continue to dominate the orthomolecular medicine market due to better availability of healthcare facilities and better disposable income.
Europe is expected to hold the second largest market share in the global orthomolecular medicine. The increasing focus towards better healthcare and the growing geriatric population in APAC are expected to boost the growth of the orthomolecular medicine market in this region.
Some of the major players in the global orthomolecular medicine include Ortho Molecular Products, Orthomol pharmazeutische Vertriebs GmbH, Nutricia North America, Nutrihand, Inc., NattoPharma, Capsumed Pharm GmbH and others.
Segmentation of the orthomolecular medicine market on the basis of product:
Segmentation of the orthomolecular medicine market on the basis of form:
Segmentation of the orthomolecular medicine market on the basis of distribution channel:
Explore Similar Insights
Orthomolecular Medicine Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
